BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts ...

Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Pacific Biosciences of California in a note issued to investors on Tuesday, February 18th. Cantor Fitzgerald analyst R. Osborn now ...

In a recent en banc decision, Delaware’s Supreme Court upheld a key tool available to employers to enforce forfeiture-for-competition ...

Fidelity integrates Lightning, Fold goes public, SEC fights crypto fraud, and bitcoiner Howard Lutnick is confirmed as U.S.

Discover why Nvidia Corporation's undervalued stock could soar, with analysts predicting strong earnings and YOY growth.

The former chair of the Wall Street firm abandoned his post as he was confirmed as the United States Commerce Secretary.